ADAM1A and colorectal carcinoma: In addition, our POD90 shotgun quantitative proteomic analysis showed increased plasma levels of two proteases, ADAM1a and ADAMTS7, of the adamalysins family in CRC/MBD patients compared to HPC (Figure 2C).